Turn Therapeutics Inc.
NASDAQ:TTRXBiotechnology
Healthcare
$8.64 -2.79%
-$0.17 today
- Market cap
- $264.15M
- Beta
- 2.77
- P/E (TTM)
- -45.0
- EPS (TTM)
- -$0.13
52W Low $2.57High $26.50
Volume 0.13M
Average 0.04M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$2.56M
FY 2025 · Annual
Investing Cash Flow
-$152,986.00
FY 2025 · Annual
Financing Cash Flow
$6.92M
FY 2025 · Annual
+500.4% YoYCash Flow Statement
USD
Metric | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|
| Net Income | (2.29M) | (1.77M) | (3.19M) |
| Depreciation & Amortization | 43.92K | 47.48K | 52.75K |
| Deferred Income Tax | 0 | 0 | 0 |
| Stock-Based Compensation | 640.26K | 352.83K | 419.25K |
| Change in Working Capital | 229.74K | (1.86K) | 2.37M |
| Accounts Receivables | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 2.26M |
| Other Working Capital | 229.74K | (1.86K) | 105.03K |
| Other Non-Cash Items | 662 | 8.65K | (2.21M) |
| Operating Cash Flow | (1.38M) | (1.36M) | (2.56M) |
| Capital Expenditures | (44.31K) | (99.48K) | (152.99K) |
| Acquisitions (Net) | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | (152.99K) |
| Investing Cash Flow | (44.31K) | (99.48K) | (152.99K) |
| Debt Repayment | 0 | 0 | 0 |
| Common Stock Issued | 500K | 1.15M | 6.92M |
| Common Stock Repurchased | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 |
| Financing Cash Flow | 500K | 1.15M | 6.92M |
| Effect of Forex Changes | 0 | 0 | 0 |
| Net Change in Cash | (921.99K) | (308.4K) | 4.2M |
| Free Cash Flow | (1.42M) | (1.46M) | (2.72M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$3.2M
+ D&A$52.7K
+ Stock-Based Comp$419.2K
+ Deferred Tax$0
+ Working Capital$2.4M
- Other Non-Cash-$2.2M
= Operating Cash Flow-$2.6M
- Capex-$153.0K
= Free Cash Flow-$2.7M
Analysis
FY2025 free cash flow is -$2.7M. FCF conversion is 85.0% of net income. Operating cash flow was -$2.6M, with capex of -$153.0K. The largest bridge item is Working Capital at $2.4M.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 10, 2026 | |
| S-3 | S-3 filing | Nov 9, 2026 | |
| 10-Q | Quarterly report | Nov 9, 2026 | |
| 8-K | Current report | Nov 9, 2026 | |
| S-3 | S-3 filing | Nov 9, 2026 |
Does TTRX generate free cash flow?
Turn Therapeutics Inc. (TTRX) generated -$2.72M of free cash flow in fiscal 2025.
How much operating cash flow does TTRX produce?
Operating cash flow was -$2.56M, before capital expenditures of $152,986.00.
Continue the stock analysis
Jump to another research area for this company.